Literature DB >> 6358284

Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature.

C Camisa, H M Sharma.   

Abstract

Vesicles and bullae complicating systemic lupus erythematosus (SLE) are relatively uncommon. Two young women with SLE presented with vesiculobullous eruptions on sun-exposed areas that resembled dermatitis herpetiformis (DH) histologically. There were active visceral manifestations of SLE in both patients, including mesangioproliferative glomerulonephritis. Granular deposits of IgG and/or IgM, along with IgA, were demonstrated along the basement membrane of skin by direct immunofluorescence microscopy. Review of fifteen additional cases of vesiculobullous SLE reported in the literature suggests that this cutaneous manifestation of SLE is associated with a high incidence of IgA deposits in skin and glomerulonephritis. The following criteria for the diagnosis of a distinct subset of vesiculobullous skin lesions occurring in patients with SLE are proposed: (1) a diagnosis of SLE based upon American Rheumatism Association (ARA) criteria; (2) vesicles and bullae arising upon but not limited to sun-exposed skin; (3) histopathology compatible with DH; (4) negative indirect immunofluorescence for circulating basement membrane zone (BMZ) antibodies; (5) direct immunofluorescence reveals IgG and/or IgM and often IgA at the BMZ.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6358284     DOI: 10.1016/s0190-9622(83)70210-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  16 in total

1.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 2.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

3.  Vesiculobullous eruption in systemic lupus erythematosus: demonstration of common anti-DNA antibody idiotype at the dermo-epidermal junction.

Authors:  J A Miller; P M Dowd; C Dudeney; D A Isenberg
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

Review 4.  [Systemic lupus erythematosus : Unusual cutaneous manifestations].

Authors:  T Stockinger; L Richter; M Kanzler; M Melichart-Kotik; H Pas; K Derfler; E Schmidt; K Rappersberger
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

5.  [Bullous systemic lupus erythematosus complicated by lupus nephritis in a 12-year-old girl].

Authors:  Zhao-Hua Xiao; Hua-Xiong Mao; Guo-Yuan Zhang; Xiang-Rong Zheng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-08

6.  Bullous systemic lupus erythematosus associated with esophagitis dissecans superficialis.

Authors:  Meera Yogarajah; Bhradeev Sivasambu; Eric A Jaffe
Journal:  Case Rep Rheumatol       Date:  2015-03-02

Review 7.  Treatment of Bullous Systemic Lupus Erythematosus.

Authors:  Lihua Duan; Liying Chen; Shan Zhong; Ying Wang; Yan Huang; Yan He; Jie Chen; Guixiu Shi
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

8.  A rare case of male bullous lupus erythematosus complicated with subsequent annular hypopigmentation.

Authors:  Saori Itoi; Atsushi Tanemura; Chie Tsuji; Shun Kitaba; Akinori Yokomi; Ichiro Katayama; Chiharu Tateishi; Daisuke Tsuruta
Journal:  Case Rep Dermatol       Date:  2014-03-19

9.  Diffuse Bullous Eruptions in an Elderly Woman: Late-Onset Bullous Systemic Lupus Erythematosus.

Authors:  Prajwal Boddu; Mojtaba Nadiri; Owais Malik
Journal:  Case Rep Dermatol       Date:  2016-10-13

10.  Bullous systemic lupus erythematosus associated with increased activity of lupus nephritis: a case report and review of the literature.

Authors:  Magdalena Żychowska; Aleksandra Batycka-Baran; Joanna Maj; Wojciech Baran
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.